Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
Investing in IPOs

Tim Eisenhauer, Managing Director of OnMarket BookBuilds recently published this article on LinkedIn which we thought might be of interest to the IR Department audience.
Tim Eisenhauer, Managing Director of OnMarket BookBuilds recently published this article on LinkedIn which we thought might be of interest to the IR Department audience.
Tim writes: "Not all IPOs are created equal. If you’re going to put your hard earned cash into the public float of a company, what are the markers of a good investment? Below are seven suggested tests that you should subject any new issue to that will hopefully put you on the plus side of the ledger when the shares actually list on the ASX."

